Compositions and methods for the diagnosis and treatment of tumor

Details for Australian Patent Application No. 2011221226 (hide)

Owner GENENTECH, INC.

Inventors Polakis, Paul; Asundi, Jyoti; Firestein, Ron; Kelley, Robert F.; McCutcheon, Krista

Agent Griffith Hack

Pub. Number AU-A-2011221226

PCT Pub. Number WO2011/106297

Priority 61/308,791 26.02.10 US; 61/307,338 23.02.10 US

Filing date 22 February 2011

Wipo publication date 1 September 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 Antineoplastic agents

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/106297 Priority application(s): WO2011/106297

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011221227-BRAF mutations conferring resistance to BRAF inhibitors

2011221225-System and method for determining a position on an implement relative to a reference position on a machine